A Case of Vogt-Koyanagi-Harada Disease-Like Uveitis Induced by Nivolumab and Ipilimumab Combination Therapy
Sign Up to like & getrecommendations! Published in 2021 at "Case Reports in Ophthalmology"
DOI: 10.1159/000520416
Abstract: Nivolumab and ipilimumab are widely used immune checkpoint inhibitors (ICPIs) for the treatment of metastatic melanoma. ICPIs cause an array of side effects called immune-related adverse events (IRAEs) due to activation of an immune response.… read more here.
Keywords: disease like; nivolumab ipilimumab; like uveitis; vkh disease ... See more keywords